Cited by 113Antifungal resistance and susceptibilityUrinary Tract Infections ManagementOcular Infections and Treatments

Oral Fluconazole Compared with Bladder Irrigation with Amphotericin B for Treatment of Fungal Urinary Tract Infections in Elderly Patients

Jacobs, L. G., Skidmore, E. A., Freeman, K., Lipschultz, D., Fox, N.·1996·Clinical Infectious Diseases

Abstract

Fungal urinary tract infections are increasingly prevalent in the elderly in acute and chronic care settings. This randomized trial compares the efficacy and safety of oral fluconazole with the efficacy and safety of bladder irrigation with amphotericin B for treatment of funguria (> or = 10,000 cfu/mL of urine) in 109 hospitalized elderly patients. A second treatment course was given for persistent funguria. Indwelling bladder catheters were present in 69% of the patients. While Candida albicans was the predominant isolate from catheterized patients, C. albicans, Candida tropicalis, and Torulopsis glabrata were recovered from noncatheterized patients. Two days after completion of treatment, funguria was eradicated in 96% of the patients treated with amphotericin B and 73% of those treated with fluconazole (P < .05). At 1 month after study enrollment, the mortality rate associated with all causes was greater among patients who were treated with amphotericin B bladder irrigation than among those who received oral fluconazole therapy (41% vs. 22%, respectively; P < .05); this finding suggests that local therapy may be associated with poorer survival. The proportion of patients without funguria at 1 month after study enrollment was similar in the two treatment groups (84%, amphotericin B group; 80%, fluconazole group). A few minor and mild adverse events occurred.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/clinids/22.1.30

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Treatment with fluconazole (200 mg/day for 7-14 days) and with amphotericin B deoxycholate at widely ranging doses (0.3-1.0 mg/kg per day for 1-7 days) has been successful for candiduria.

    “Treatment with fluconazole (200 mg/ day for 7-14 days) and with amphotericin B deoxycholate at widely ranging doses (0.3-1.0 mg/kg per day for 1-7 days) has been successful [172] (B-II).”

    From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [172]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Joseph CL, Strausbaugh LJ. Funguria in the nursing home. Nursing Home Medicine 1994;2:161-6.
  2. Castiglia M, Fisher M. Use of fluconazole in the treatment of candiduria: a retrospective view [abstract F-49]. In: Proceedings of the 93rd General Meeting of the American Society for Microbiology (Atlanta). Washing- ton, DC: American Society for Microbiology, 1993:535.

Cited by

Sorted by citations

Authors
Jacobs, L. G., Skidmore, E. A., Freeman, K., Lipschultz, D., & Fox, N.
Affiliations
  • Montefiore Medical Center (US)
  • Albert Einstein College of Medicine (US)
Corresponding author
Jacobs, L. G.
Venue
Clinical Infectious Diseases
Published
1996-01-01
Volume
22
Issue
1
Pages
30-35
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2117917197
Cited by
113
References
27
Citations by year
2026: 4 · 2025: 2 · 2024: 1 · 2022: 1 · 2020: 4 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 2 · 2013: 2
FWCI
5.54
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
Pfizer
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Epidemiology › Urinary Tract Infections Management
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
fungal urinary tract infection, funguria, fluconazole, amphotericin B, bladder irrigation, elderly patients, indwelling urinary catheter, Candida albicans, Candida tropicalis, Candida glabrata, mortality, treatment efficacy and safety
MeSH terms
Administration, Oral, Aged, Aged, 80 and over, Amphotericin B, Urinary Bladder, Candidiasis, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Therapeutic Irrigation, Male, Urinary Tract Infections, Fluconazole, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review